Multiple treatment modalities for brain metastasis in patients with EGFR-mutant non-small-cell lung cancer

BACKGROUND: There are many controversies concerning the best management of epidermal growth factor receptor (EGFR)-mutant non-small-cell lung cancer (NSCLC) patients with brain metastases (BMs). The use of upfront EGFR tyrosine kinase inhibitors (TKIs) and the withholding of local therapies or upfro...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Haiyang, Yu, Xiaoqing, Fan, Yun, Jiang, Youhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5907894/
https://www.ncbi.nlm.nih.gov/pubmed/29713183
http://dx.doi.org/10.2147/OTT.S156570

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5907894/
https://www.ncbi.nlm.nih.gov/pubmed/29713183
http://dx.doi.org/10.2147/OTT.S156570

Ejemplares similares